Lavasanifar A - Search Results

1

Pharmacokinetics of PSC 833 (valspodar) in its Cremophor EL formulation in rat.

Binkhathlan Z, Hamdy DA, Brocks DR, Lavasanifar A. Binkhathlan Z, et al. Among authors: lavasanifar a. Xenobiotica. 2010 Jan;40(1):55-61. doi: 10.3109/00498250903331056. Xenobiotica. 2010. PMID: 19903013

2

Polymeric micelles for the solubilization and delivery of cyclosporine A: pharmacokinetics and biodistribution.

Aliabadi HM, Brocks DR, Lavasanifar A. Aliabadi HM, et al. Among authors: lavasanifar a. Biomaterials. 2005 Dec;26(35):7251-9. doi: 10.1016/j.biomaterials.2005.05.042. Biomaterials. 2005. PMID: 16005061

3

Development of a sensitive and specific liquid chromatography/mass spectrometry method for the quantification of cucurbitacin I (JSI-124) in rat plasma.

Molavi O, Shayeganpour A, Somayaji V, Hamdy S, Brocks DR, Lavasanifar A, Kwon GS, Samuel J. Molavi O, et al. Among authors: lavasanifar a. J Pharm Pharm Sci. 2006;9(2):158-64. J Pharm Pharm Sci. 2006. PMID: 16959185 Free article.

4

Insights into the effects of hyperlipoproteinemia on cyclosporine A biodistribution and relationship to renal function.

Aliabadi HM, Spencer TJ, Mahdipoor P, Lavasanifar A, Brocks DR. Aliabadi HM, et al. Among authors: lavasanifar a. AAPS J. 2006 Oct 27;8(4):E672-81. doi: 10.1208/aapsj080477. AAPS J. 2006. PMID: 17233531 Free PMC article.

5

High-performance liquid chromatography analysis of curcumin in rat plasma: application to pharmacokinetics of polymeric micellar formulation of curcumin.

Ma Z, Shayeganpour A, Brocks DR, Lavasanifar A, Samuel J. Ma Z, et al. Among authors: lavasanifar a. Biomed Chromatogr. 2007 May;21(5):546-52. doi: 10.1002/bmc.795. Biomed Chromatogr. 2007. PMID: 17340565

6

A novel use of an in vitro method to predict the in vivo stability of block copolymer based nano-containers.

Aliabadi HM, Brocks DR, Mahdipoor P, Lavasanifar A. Aliabadi HM, et al. Among authors: lavasanifar a. J Control Release. 2007 Sep 11;122(1):63-70. doi: 10.1016/j.jconrel.2007.06.008. Epub 2007 Jun 16. J Control Release. 2007. PMID: 17644207

7

Polymeric micellar delivery reduces kidney distribution and nephrotoxic effects of Cyclosporine A after multiple dosing.

Aliabadi HM, Elhasi S, Brocks DR, Lavasanifar A. Aliabadi HM, et al. Among authors: lavasanifar a. J Pharm Sci. 2008 May;97(5):1916-26. doi: 10.1002/jps.21036. J Pharm Sci. 2008. PMID: 17786948

8

Development of a liquid chromatography-mass spectrometry (LC/MS) assay method for the quantification of PSC 833 (Valspodar) in rat plasma.

Binkhathlan Z, Somayaji V, Brocks DR, Lavasanifar A. Binkhathlan Z, et al. Among authors: lavasanifar a. J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Jun 15;869(1-2):31-7. doi: 10.1016/j.jchromb.2008.05.003. Epub 2008 May 10. J Chromatogr B Analyt Technol Biomed Life Sci. 2008. PMID: 18514043

9

Disposition of drugs in block copolymer micelle delivery systems: from discovery to recovery.

Aliabadi HM, Shahin M, Brocks DR, Lavasanifar A. Aliabadi HM, et al. Among authors: lavasanifar a. Clin Pharmacokinet. 2008;47(10):619-34. doi: 10.2165/00003088-200847100-00001. Clin Pharmacokinet. 2008. PMID: 18783294 Review.

10

An analytical method for cyclosporine using liquid chromatography-mass spectrometry.

Kanduru SV, Somayaji V, Lavasanifar A, Brocks DR. Kanduru SV, et al. Among authors: lavasanifar a. Biomed Chromatogr. 2010 Feb;24(2):148-53. doi: 10.1002/bmc.1263. Biomed Chromatogr. 2010. PMID: 19591121

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

175 results

Search Page

Filters